Literature DB >> 20940318

Syk is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor.

Beate Heizmann1, Michael Reth, Simona Infantino.   

Abstract

Upon B-cell activation, the signaling subunits Ig-α and Ig-β of the B-cell antigen receptor become phosphorylated not only on tyrosines but also on serine residues. Using a specific antibody, we show that serine 197 (S197) in the cytoplasmic tail of Ig-α is phosphorylated upon B-cell antigen receptor activation, and that this modification inhibits the signal output of the B-cell antigen receptor. Surprisingly, we found that the well-known protein tyrosine kinase Syk (spleen tyrosine kinase) phosphorylates S197 on Ig-α, thus not only activating but also inhibiting signaling from the B-cell antigen receptor. This finding identifies Syk as a dual-specificity kinase and establishes a previously unexplored paradigm for the self-regulation of biological signaling processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940318      PMCID: PMC2972992          DOI: 10.1073/pnas.1009048107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Characterization of molecular components associated with surface immunoglobulin M in human B lymphocytes: presence of tyrosine and serine/threonine protein kinases.

Authors:  C Leprince; K E Draves; J A Ledbetter; R M Torres; E A Clark
Journal:  Eur J Immunol       Date:  1992-08       Impact factor: 5.532

2.  Identification of two distinct phosphoproteins as components of the human B cell antigen receptor complex.

Authors:  C J Van Noesel; J Borst; E F De Vries; R A Van Lier
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

Review 3.  The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction.

Authors:  R A Mufson
Journal:  FASEB J       Date:  1997-01       Impact factor: 5.191

4.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

5.  Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.

Authors:  A L Bothwell; M Paskind; M Reth; T Imanishi-Kari; K Rajewsky; D Baltimore
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

6.  Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase.

Authors:  L Gandino; P Longati; E Medico; M Prat; P M Comoglio
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

7.  Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases.

Authors:  S A Johnson; C M Pleiman; L Pao; J Schneringer; K Hippen; J C Cambier
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

8.  Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen.

Authors:  T Kobayashi; S Nakamura; T Taniguchi; H Yamamura
Journal:  Eur J Biochem       Date:  1990-03-30

9.  Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation.

Authors:  R B Rowley; A L Burkhardt; H G Chao; G R Matsueda; J B Bolen
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

10.  Activation and serine phosphorylation of the p56lck protein tyrosine kinase in response to antigen receptor cross-linking in B lymphocytes.

Authors:  M R Gold; R Chiu; R J Ingham; T M Saxton; I van Oostveen; J D Watts; M Affolter; R Aebersold
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

View more
  21 in total

1.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

2.  Encephalomyocarditis virus leader is phosphorylated by CK2 and syk as a requirement for subsequent phosphorylation of cellular nucleoporins.

Authors:  Holly A Basta; Valjean R Bacot-Davis; Jessica J Ciomperlik; Ann C Palmenberg
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model.

Authors:  Wei Du; Rebecca Goldstein; Yanwen Jiang; Omar Aly; Leandro Cerchietti; Ari Melnick; Olivier Elemento
Journal:  Cancer Res       Date:  2017-01-27       Impact factor: 12.701

Review 4.  Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.

Authors:  Mariya O Krisenko; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2014-11-04

5.  A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn.

Authors:  Dipak Barua; William S Hlavacek; Tomasz Lipniacki
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

6.  Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation.

Authors:  Heide Christine Patterson; Manfred Kraus; Donghai Wang; Aliakbar Shahsafaei; Joel M Henderson; Jane Seagal; Kevin L Otipoby; To-Ha Thai; Klaus Rajewsky
Journal:  J Immunol       Date:  2011-08-12       Impact factor: 5.422

7.  Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Authors:  Fatih M Uckun; Hong Ma; Jian Zhang; Zahide Ozer; Sinisa Dovat; Cheney Mao; Rita Ishkhanian; Patricia Goodman; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

8.  In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates.

Authors:  Grant C Weaver; Rina F Villar; Masaru Kanekiyo; Gary J Nabel; John R Mascola; Daniel Lingwood
Journal:  Nat Protoc       Date:  2016-01-07       Impact factor: 13.491

Review 9.  Getting Syk: spleen tyrosine kinase as a therapeutic target.

Authors:  Robert L Geahlen
Journal:  Trends Pharmacol Sci       Date:  2014-06-26       Impact factor: 14.819

10.  Unperturbed Immune Function despite Mutation of C-Terminal Tyrosines in Syk Previously Implicated in Signaling and Activity Regulation.

Authors:  Vanessa Weis; Sebastian Königsberger; Susanne Amler; Jürgen Wienands; Friedemann Kiefer
Journal:  Mol Cell Biol       Date:  2017-10-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.